ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,728, issued on July 21, was assigned to AMNEAL PHARMACEUTICALS LLC (Bridgewater, N.J.).
"Anti-vertigo compound and pharmaceutical compositions thereof" was invented by Nirav Vyas (Ahmedabad, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to uses of Levocloperastine for the treatment or prevention of vertigo, disease associated with vertigo or symptoms associated therewith. Further, the invention also relates to oral pharmaceutical composition comprising Levocloperastine and one or more pharmaceutical excipients and its preparation process."
The patent was filed on Sept. 10, 2021, under Application No. 18/033,993....